BioPharma Dive 8. Apr. 2026 Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
FierceBiotech 7. Apr. 2026 Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
Endpoints News 2. Apr. 2026 Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News 2. Apr. 2026 Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News 1. Apr. 2026 Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
FierceBiotech 31. März 2026 Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
Insilico Medicine 29. März 2026 Insilico Medicine Announces Global R&D Collaboration with Lilly - Insilico Medicine
FierceBiotech 23. März 2026 Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
Endpoints News 20. März 2026 UK’s NICE revisits Lilly, Eisai Alzheimer's drugs under new pricing threshold